{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:01:40Z","timestamp":1794049300047,"version":"4.8.0"},"reference-count":123,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>We conducted an analytic review of the clinical scientific literature bearing on the use of opioids for treatment of chronic non-cancer pain in the United States. There is substantial, albeit not definitive, scientific evidence of the effectiveness of opioids in treating pain and of high variability in opioid dose requirements and side effects. The estimated risk of death from opioid treatment involving doses above 100 MMED is ~0.25%\/year. Multiple large studies refute the concept that short-term use of opioids to treat acute pain predisposes to development of opioid use disorder. The prevalence of opioid use disorder associated with prescription opioids is likely &amp;lt;3%. Morbidity, mortality, and financial costs of inadequate treatment of the 18 million Americans with moderate to severe chronic pain are high. Because of the absence of comparative effectiveness studies, there are no scientific grounds for considering alternative non-pharmacologic treatments as an adequate substitute for opioid therapy but these treatments might serve to augment opioid therapy, thereby reducing dosage. There are reasons to question the ostensible risks of co-prescription of opioids and benzodiazepines. As the causes of the opioid crisis have come into focus, it has become clear that the crisis resides predominantly in the streets and that efforts to curtail it by constraining opioid treatment in the clinic are unlikely to succeed.<\/jats:p>","DOI":"10.3389\/fpain.2021.721357","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:28:14Z","timestamp":1629181694000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":96,"title":["Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence"],"prefix":"10.3389","volume":"2","author":[{"given":"Stephen E.","family":"Nadeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Lawhern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR."},{"key":"B2","year":"2018","journal-title":"Draft Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations."},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.pmn.2019.05.004","article-title":"Misperceptions about the \u2018opioid epidemic:\u2019 exploring the facts","volume":"21","author":"Oliver","year":"2020","journal-title":"Pain Manag Nurs."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain. a systematic review and meta-analysis","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1155\/2011\/465281","article-title":"A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain","volume":"16","author":"Furlan","year":"2011","journal-title":"Pain Res Manage."},{"key":"B7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/BRS.0000000000000249","article-title":"Opioids compared with placebo or other treatments for chronic low back pain","volume":"39","author":"Chaparro","year":"2014","journal-title":"Spine."},{"key":"B8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1213\/00000539-200004000-00029","article-title":"Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review","volume":"90","author":"Quang-Cantagrel","year":"2000","journal-title":"Anesth Analg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1200\/JCO.2001.19.9.2542","article-title":"Strategies to manage the adverse effects of oral morphine: an evidence-based report","volume":"19","author":"Cherny","year":"2001","journal-title":"J Clin Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/archinte.160.6.853","article-title":"Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain","volume":"160","author":"Roth","year":"2000","journal-title":"Arch Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1054\/jpai.2001.25352","article-title":"Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain","volume":"2","author":"Milligan","year":"2001","journal-title":"J Pain."},{"key":"B13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1526-5900(03)00632-1","article-title":"Long-term management of noncancer pain with transdermal therapeutic system-fentanyl","volume":"4","author":"Mystakidou","year":"2003","journal-title":"J Pain."},{"key":"B14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/AJP.0b013e31802b582f","article-title":"Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Clin J Pain."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1212\/WNL.65.12_suppl_4.S32","article-title":"Methodological issues in clinical trials of opioids for chronic pain","volume":"65","author":"Katz","year":"2005","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jpain.2006.09.011","article-title":"Study Group 1. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study","volume":"8","author":"Hale","year":"2007","journal-title":"J Pain."},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpain.2004.09.005","article-title":"Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study","volume":"6","author":"Hale","year":"2005","journal-title":"J Pain."},{"key":"B18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1185\/030079906X162692","article-title":"A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain","volume":"23","author":"Katz","year":"2007","journal-title":"Curr Med Res Opinion."},{"key":"B19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/pme.12377","article-title":"Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study","volume":"15","author":"Rauck","year":"2014","journal-title":"Pain Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/j.pain.0000000000000315","article-title":"A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain","volume":"156","author":"Katz","year":"2015","journal-title":"Pain."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain."},{"key":"B22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2147\/JPR.S160255","article-title":"Efficacy of opioids versus placebo in chronic pain: a systematic rerview and meta-analysis of enriched enrollment randomized withdrawal trials","volume":"11","author":"Meske","year":"2018","journal-title":"J Pain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/AJP.0b013e3181b12dec","article-title":"Enriched enrollment randomized withdrawal trial designs of analgesics. Focus on methodology","volume":"25","author":"Katz","year":"2009","journal-title":"Clin J Pain."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br J Anaesth."},{"key":"B25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5535\/arm.2014.38.5.665","article-title":"Correlations between electrically quantified pain degree, subjectively assessed visual analogue scale, and the McGill Pain Questionnaire: a pilot study","volume":"38","author":"Kim","year":"2014","journal-title":"Ann Rehabil Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2018.0899","article-title":"Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain. The SPACE randomized clinical trial","volume":"319","author":"Krebs","year":"2018","journal-title":"JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effective of atypical antipshychotic drugs in patients with Alzheimer's disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N Engl J Med."},{"key":"B28","first-page":"5","article-title":"The case for patient-controlled analgesia","volume":"30","author":"Beeton","year":"1992","journal-title":"S AfrJ Surg."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1213\/01.ANE.0000080153.36643.83","article-title":"Women experience more pain and require more morphine than men to achieve a similar degree of analgesia","volume":"97","author":"Cepeda","year":"2003","journal-title":"Anesth Analg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijoa.2008.06.006","article-title":"A double-blind randomized controlled trial of patient-controlled epidural analgesia with or without a background infusion following initial spinal analgesia for labor pain","volume":"18","author":"Okutomi","year":"2009","journal-title":"Int J Obstet Anesth."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1245\/s10434-013-3064-9","article-title":"Postoperative pain medication requirements in patients undergoing computer-assisted (\u201crobotic\u201d) and standard laparoscopic procedures for newly diagnosed endometrial cancer","volume":"20","author":"Leitao","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40122-017-0069-2","article-title":"Genetic testing for opioid pain management","volume":"6","author":"Agarwal","year":"2017","journal-title":"Pain Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/phar.1986","article-title":"Review of opioid pharmacogenetics and considerations for pain management","volume":"27","author":"Obeng","year":"2017","journal-title":"Pharmacotherapy."},{"key":"B34","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.pnpbp.2019.02.010","article-title":"Members of the same opioid family are not alike; different opioids, different consequences, hope for the opioid crisis?","volume":"92","author":"Emery","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1158\/1078-0432.CCR-10-3028","article-title":"Multiple loci modulate opioid therapy response for cancer pain","volume":"17","author":"Galvan","year":"2011","journal-title":"Clin Can Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.36076\/ppj.2014\/17\/425","article-title":"A review of the role of genetic testing in pain medicine","volume":"17","author":"Trescot","year":"2014","journal-title":"Pain Physician."},{"key":"B37","volume-title":"Balancing Society and Individual Benefits and Risks of Prescription Opioid Use","year":"2017"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA."},{"key":"B40","first-page":"13","article-title":"Trends in opioid use and dosing among socio-economically disadvantaged patients","volume":"5","author":"Gomes","year":"2011","journal-title":"Open Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pme.12907","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.amepre.2019.09.022","article-title":"Opioid prescribing patterns before fatal opioid overdose","volume":"58","author":"Abbasi","year":"2020","journal-title":"Am J Prev Med."},{"key":"B43","year":"2016","journal-title":"\u201cAn Assessment of Opioid-Related Deaths in Massachusetts (2013-2014)\u201d"},{"key":"B44","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s11606-019-05501-w","article-title":"Opioid prescriptions and short-term mortality: a U.S. national study","volume":"35","author":"Agnoli","year":"2020","journal-title":"J Gen Intern Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/00325481.2017.1297668","article-title":"Chronic pain management in medical education: a disastrous omission","volume":"129","author":"Loeser","year":"2017","journal-title":"Postgrad Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"J Gen Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1212\/WNL.0000000000001766","article-title":"Opioids for chronic nonmalignant pain. To prescribe or not to prescribe\u2014what is the question?","volume":"85","author":"Nadeau","year":"2015","journal-title":"Neurology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","year":"2020","journal-title":"Eur Heart J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182,678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJMsr1601307","article-title":"A proactive response to prescription opioid abuse","volume":"374","author":"Califf","year":"2016","journal-title":"N Engl J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0304-3959(89)90097-3","article-title":"Opioid pseudo-addiction\u2014an iatrogenic syndrome","volume":"36","author":"Weissman","year":"1989","journal-title":"Pain."},{"key":"B53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1526-4637.2007.00370.x","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? a structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chonic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bja.2018.03.009","article-title":"Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis","volume":"120","author":"Higgins","year":"2018","journal-title":"Br J Anaesth."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain \u2014 misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drugalcdep.2015.12.026","article-title":"Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study","volume":"160","author":"Carlson","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/SAR.S85667","article-title":"Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates","volume":"6","author":"Boscarino","year":"2015","journal-title":"Subst Abuse Rehabil."},{"key":"B60","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders\u2014Opioid Use Disorder Diagnostic Criteria"},{"key":"B61","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.drugpo.2017.05.053","article-title":"Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives","volume":"46","author":"Von Korff","year":"2017","journal-title":"Int J Drug Policy."},{"key":"B62","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"j5790","DOI":"10.1136\/bmj.j5790","article-title":"Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study","volume":"360","author":"Brat","year":"2018","journal-title":"BMJ."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/JPR.S144066","article-title":"Poorly controlled postoperative pain: prevalence, consequences, and prevention","volume":"10","author":"Gan","year":"2017","journal-title":"J Pain Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jamainternmed.2016.3298","article-title":"Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period","volume":"176","author":"Sun","year":"2016","journal-title":"JAMA Intern Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.juro.2017.05.037","article-title":"Rates and risk factors for opioid dependence and overdose after urological surgery","volume":"198","author":"Shah","year":"2017","journal-title":"J Urol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use \u2014 United States, 2006-2015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR."},{"key":"B68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/08897077.2017.1345194","article-title":"Will strict limits on opioid prescription duration prevent addiction? Advocating for evidence-based policymaking","volume":"38","author":"Mundkur","year":"2017","journal-title":"Subst Abuse."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e170504","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e207367","DOI":"10.1001\/jamanetworkopen.2020.7367","article-title":"Rate and risk factors associated with prolonged opioid use after surgery. a systematic review and meta-analysis","volume":"3","author":"Lawal","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"key":"B72","doi-asserted-by":"publisher","first-page":"k2833","DOI":"10.1136\/bmj.k2833","article-title":"Trends in opioid use in commercially insured and medicare advantage populations in 2007-2016: retrospective cohort study","volume":"362","author":"Jeffery","year":"2018","journal-title":"BMJ."},{"key":"B73","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1399-6576.2007.01524.x","article-title":"Chronic non-malignant pain patients report as poor health-related quality of life as palliative cancer patients","volume":"52","author":"Fredheim","year":"2008","journal-title":"Acta Anaesthesiol Scand."},{"key":"B74","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ejpain.2009.07.006","article-title":"Severe chronic pain is associated with increased 10 year mortality. a cohort record linkage study","volume":"14","author":"Torrance","year":"2010","journal-title":"Eur J Pain."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/j.pain.0000000000001193","article-title":"Pain and mortality: mechanisms for a relationship","volume":"159","author":"Smith","year":"2018","journal-title":"Pain."},{"key":"B76","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.pneurobio.2011.01.002","article-title":"The effect of pain on cognitive function: a review of clinical and preclinical research","volume":"93","author":"Moriarity","year":"2011","journal-title":"Progr Neurobiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/j.pain.0000000000001491","article-title":"Chronic pain is associated with a brain aging biomarker in community-dwelling older adults","volume":"160","author":"Cruz-Almeida","year":"2019","journal-title":"Pain."},{"key":"B78","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1017\/S0033291705006859","article-title":"Suicidality in chronic pain: a review of the prevalence, risk factors, psychological links","volume":"36","author":"Tang","year":"2006","journal-title":"Psychol Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or sicide deaths in US veterans: observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ."},{"key":"B80","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.genhosppsych.2008.09.003","article-title":"Pain and suicidal thoughts, plans and attempts in the United States","volume":"30","author":"Ilgen","year":"2008","journal-title":"Gen Hosp Psychiatry."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1498","DOI":"10.1097\/MD.0000000000001498","article-title":"Subacute pain as a predictor of long-term pain following orthopedic surgery: an Australian prospective 12 month observational cohort study","volume":"94","author":"Veal","year":"2015","journal-title":"Medicine."},{"key":"B82","article-title":"Relieving Pain in America","volume-title":"A Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1001\/archinternmed.2010.391","article-title":"The comparative safety of analgesics in older adults with arthritis with arthritis","volume":"170","author":"Solomon","year":"2010","journal-title":"Arch Intern Med."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.23970\/AHRQEPCCER209","article-title":"Noninvasive nonpharmacological treatment for chronic pain: a systematic review (AHRQ Publication No","author":"Skelly","year":"2018"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.23970\/AHRQEPCCER227","article-title":"Noninvasive nonpharmacological treatment for chronic pain: A systematic review update","author":"Skelly","year":"2020"},{"key":"B87","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/pm\/pny027","article-title":"Evaluation of complementary and integrative health approaches among veterans with musculoskeletal pain using propensity score methods","volume":"20","author":"Han","year":"2018","journal-title":"Pain Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamainternmed.2019.4917","article-title":"Mind-body therapies for opioid-treated pain. a systematic review and meta-analysis","volume":"180","author":"Garland","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"J760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ."},{"key":"B90","doi-asserted-by":"publisher","first-page":"493","DOI":"10.36076\/ppj.2009\/12\/493","article-title":"The marginalization of patients on chronic opioid therapy","volume":"12","author":"Peppin","year":"2009","journal-title":"Pain Physician."},{"key":"B91","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receriving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e2028577","DOI":"10.1001\/jamanetworkopen.2020.28557","article-title":"Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015","volume":"3","author":"Xu","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/pme.12777","article-title":"Development of a risk index of serious prescription opioid-induced respiratory depression or overdose in Veterans' health administration patients","volume":"16","author":"Zedler","year":"2015","journal-title":"Pain Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1037\/0033-2909.119.1.95","article-title":"Explaining high rates of depression in chronic pain: a diathesis-stress framework","volume":"119","author":"Banks","year":"1996","journal-title":"Psychol Bul."},{"key":"B95","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/j.pain.0000000000001133","article-title":"Pain as a risk factor for common mental disorders. Results from the Netherlands Mental Health Survey and Incidence Study-2: a longitudinal, population-based study","volume":"159","author":"de Heer","year":"2018","journal-title":"Pain."},{"key":"B96","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0140-6736(09)60879-5","article-title":"Clinical diagnosis of depression in primary care: a meta-analysis","volume":"374","author":"Mitchell","year":"2009","journal-title":"Lancet."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1001\/archinternmed.2010.273","article-title":"Emergency department visits among recipients of chronic opioid therapy","volume":"170","author":"Braden","year":"2010","journal-title":"Arch Intern Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/070674371305800802","article-title":"Depression in primary care: current and future challenges","volume":"58","author":"Craven","year":"2013","journal-title":"Can J Psychiatr."},{"key":"B100","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.genhosppsych.2009.07.003","article-title":"Trends in long-term opioid therapy for noncancer pain among people with a history of depression","volume":"31","author":"Braden","year":"2009","journal-title":"Gen Hosp Psychiatry."},{"key":"B101","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/j.pain.0000000000000730","article-title":"Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims","volume":"158","author":"Quinn","year":"2017","journal-title":"Pain."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2333392818771243","article-title":"Depression and anxiety among patients on chronic opioid therapy","volume":"5","author":"Elrashidi","year":"2018","journal-title":"Health Serv Res Manag Epidemiol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"8070816","DOI":"10.1001\/archpsyc.61.8.807","article-title":"Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders","volume":"61","author":"Grant","year":"2004","journal-title":"Arch Gen Psychiatry."},{"key":"B104","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1370\/afm.1371","article-title":"Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse","volume":"10","author":"Grattan","year":"2012","journal-title":"Ann Fam Med."},{"key":"B105","unstructured":"Drug Overdose Deaths in the United States, 1999-2016.2017"},{"key":"B106","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014-2016","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.2147\/JPR.S153322","article-title":"Pain management, prescription opioid mortality, and the CDC: is the devil in the data?","volume":"10","author":"Schatman","year":"2017","journal-title":"J Pain Res."},{"key":"B108","unstructured":"Understanding the Epidemic.2019"},{"key":"B109","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2014 United States, 2013-2019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR."},{"key":"B110","unstructured":"U.S. Prescribing Rate Maps2017"},{"key":"B111","unstructured":"CDC Wonder2019"},{"key":"B112","unstructured":"MDM Market Leaders | Top Pharmaceutical Distributors\n            FeinAJ\n          2017"},{"key":"B113","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am J Pub Health."},{"key":"B114","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/pm\/pnx048","article-title":"Are prescription opioids driving the opioid crisis? assumptions vs facts","volume":"19","author":"Rose","year":"2018","journal-title":"Pain Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/JPR.S199750","article-title":"Today's nonmedical opioid users are not yesterday's patients; implications of data indicating stable reates of nonmedical use and pain reliever use disorder","volume":"12","author":"Singer","year":"2019","journal-title":"J Pain Res."},{"key":"B116","unstructured":"HighamS\n            HorwitzS\n            RichS\n          76 Billion Opioid Pills: Newly Released Federal Data Unmasks the Epidemic2019"},{"key":"B117","article-title":"S. Department of Health, and Human Services and Office of the Surgeon General (HHS)","year":"2016","journal-title":"Facing Addiction in America. The Surgeon General's Report on Alcohol, Drugs, and Health"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1176\/appi.ajp.2007.07050252","article-title":"Prescription Oxycontin abuse among patients entering addiction treatment","volume":"164","author":"Carise","year":"2007","journal-title":"Am J Psychiatry."},{"key":"B119","doi-asserted-by":"crossref","DOI":"10.3386\/w23031","volume-title":"Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterent Opioids (Working Paper 23031)","author":"Alpert","year":"2017"},{"key":"B120","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.addbeh.2017.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse","volume":"74","author":"Cicero","year":"2017","journal-title":"Addict Behav."},{"key":"B121","article-title":"Centers for Disease Control, Prevention","year":"2017","journal-title":"Annual Surveillance Report of Drug-Related Risks and Outcomes"},{"key":"B122","volume-title":"Proceedings of the Prescribing Policies: States Confront Opioid Overdose Epidemic","year":"2018"},{"key":"B123","unstructured":"Re: Docket NoCDC-2020\u2013C-0029. AMA's - American Medical Association2020"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2021.721357\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:28:25Z","timestamp":1629181705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2021.721357\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":123,"alternative-id":["10.3389\/fpain.2021.721357"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2021.721357","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"article-number":"721357"}}